The US Supreme Court on Friday stayed two lower court rulings reversing FDA approval of the abortion drug mifepristone, preserving access while the litigation continues, the AP reports.
The US Supreme Court on Friday stayed two lower court rulings reversing FDA approval of the abortion drug mifepristone, preserving access while the litigation continues, the AP reports.